Page last updated: 2024-11-06

floxuridine and Infections, Staphylococcal

floxuridine has been researched along with Infections, Staphylococcal in 2 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research Excerpts

ExcerptRelevanceReference
" In this study, we screened 12,200 small molecules for Sae inhibitors and identified two anti-cancer drugs, streptozotocin (STZ) and floxuridine (FU), as lead candidates for anti-virulence drug development against staphylococcal infections."3.88The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus. ( Arya, R; Bae, T; Cho, KH; Jeong, H; Kim, KK; Yeo, WS, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sandrini, MP1
Shannon, O1
Clausen, AR1
Björck, L1
Piskur, J1
Yeo, WS1
Arya, R1
Kim, KK1
Jeong, H1
Cho, KH1
Bae, T1

Other Studies

2 other studies available for floxuridine and Infections, Staphylococcal

ArticleYear
Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Deoxycytidine; Female; Gemcitabine; Humans; Mice; Mice, Inbred BALB

2007
The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus.
    Scientific reports, 2018, 02-06, Volume: 8, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Proteins; Blood Cell Count; Blood G

2018